Human dental pulp cells (hDPCs) express oestrogen receptor (ER) isoforms ER , ER 1 and ER 2, as well as a 7-transmembrane G protein-coupled receptor, GPR30, that mediates rapid oestrogen signalling. Following osteogenic differentiation of these cells ER 1 and ER 2 were up regulated approximately 50-fold while ER and GPR30 were down regulated, but to a much lesser degree (approximately 2-fold). ER was characterised as a 59 kDa protein following SDS-PAGE. ER was detected in both nuclear and cytoplasmic cell compartments following immunofluorescence of cultured cells. Furthermore isoform specific antibodies detected both ER 1 and ER 2 in DPC cultures and in situ analysis of ER expression in decalcified tooth/pulp sections identified the odontoblast layer of pulp cells juxtaposed to the tooth enamel as strongly reactive for both ER isoforms. Finally the use of isoform specific agonists identified ER as the main receptor responsible for the proosteogenic effect of oestrogenic hormones in this tissue. 
Introduction
Tooth loss (edentulism) is associated with reduction of alveolar bone mass in postmenopausal women [1] [2] [3] and can be counteracted by oestrogen replacement therapy [4] [5] [6] [7] .
Similarly alterations in local and systemic oestrogen concentrations as seen during use of chemical contraception or in patients undergoing adjuvant therapeutic strategies in hormone dependant breast cancer is associated with challenges to periodontal health [8] [9] [10] . Despite these important epidemiological findings very little is known about the mechanism of action of oestradiol (E 2 ) within the cells and tissues of the oral cavity. In most cells E 2 binds to cytosolic oestrogen receptors (ERs) which translocate to the nucleus and regulate gene expression in association with other trans and cis acting factors. In addition a cell membrane associated 7TM G protein linked ER (GPR30) is associated with the acute E 2 action in many cells. [11, 12] Several tissues within the oral cavity contain populations of mesenchymal stem cells (MSCs) [13] [14] [15] [16] which are able to differentiate into a matrix mineralising phenotype and this can be stimulated by the action of E 2 [17, 18] . Accordingly, ER mRNA and protein is expressed in niche MSC populations in the oral cavity including those from periodontal ligament-PDLCs- [19, 20] and dental pulp-DPCs [21, 22] although the proteins remain rather poorly characterised in these tissues. Two classical ER isoforms have been described-ER and ER -which are structurally and functionally related but which represent two different gene products [23, 24] . Although PDLCs and DPCs are reported to express both ER isoforms, the literature is conflicted with regard to which ER isoform(s) are involved in the differentiation of cells to a matrix mineralising phenotype [25] [26] [27] [28] and there is little information on the contribution of ER isoforms to the differentiation of stem cell populations from other tissue niches within the oral cavity. For these reasons we have characterised ER isoform expression and function in DPCs isolated from healthy third molars at the cellular and whole tissue level using qRT-PCR, Western blotting, IHC and IF. In addition we have used isoform specific agonists to determine the activity of ER and ER during differentiation of these cells to a matrix mineralisation phenotype.
Materials
Phenol red free -MEM, dextran charcoal stripped serum (DCS) and phosphate buffered saline (PBS) was from Lonza (Slough, UK); penicillin/streptomycin (PS), L-glutamine, Lascorbic acid and dexamethasone, were from Sigma (Dorset, UK). Collagenase (Type I), 
Methods

Tissue culture
Isolation, growth and differentiation of DPCs were essentially as described previously [29] with the exception that cells were maintained and passaged in Phenol Red free MEM containing, 10% dextran charcoal-stripped serum (PR-DCS). Similarly all experiments (qRT-PCR, WB, IF, IHC and in vitro bioassay) were done in cells grown in this medium. Unless otherwise stated experiments were performed on DPCs derived from healthy pulps from three separate donors and triplicate technical replicates were performed in each instance.
qRT-PCR Details of mRNA purification, cDNA synthesis, and qRT-PCR and data analysis have also been described previously [29, 30] . Routinely osteogenic markers ALP, OCN, Runx2 and oestrogen receptor isoforms ER , ER 1, ER 2 and GPR30 were assayed using TaqMan probes and primers. GAPDH or HGPRT were used as house-keeping genes. Assay identifiers for TaqMan qRT-PCR reactions are presented in Supplementary Table 2.
Western blot
DPCs were cultured for 7, 14 or 21 day under basal or osteogenic conditions and cell lysates were prepared using NP40 cell lysis buffer. Protein was quantified using Pierce™ BCA protein assay and lysates were stored at -20 ºC prior to analysis. Lysates containing equivalent amounts of protein (typically 30-50 ug) were diluted in x4 Laemmli sample buffer containing -mercaptoethanol (5% final concentration) and electrophoresed through 4-15% gradient SDS-PAGE gels for 1h at 120 V. Proteins were transferred to PVDF semi dry membranes using the Trans-Blot Turbo (BioRad) for 10 minutes. Membranes were blocked with TBS containing 5% BSA and 0.1% Tween20 (blocking buffer) for at least 1hour on a shaker at room temperature. Subsequently, membranes were incubated overnight room temperature (RT) with anti-ER-antibodies Ab 288 and MC10 (1:200; a kind gift from Dr John Hawse [31] ) in TBS containing 0.1% Tween20 (TBS-T). These antibodies have been extensively validated for specificity in WB applications [31, 32] Membranes were washed x5 with TBS-T and incubated with anti-mouse horseradish peroxidase (HRP) conjugated secondary antibody (1:100000) for 2 hours at room temperature in TBS-T. Membranes were washed x4 with TBST and x1 with TBS, and developed with ECL substrate. Images were processed and stored on the Gel-Doc system (Bio-Rad). For quantitation and densitometry blots were stripped with WB stripping buffer and re-probed with anti-actin.
Immunofluorescence (IF)
DPCs at passage 4 were seeded in PR-DCS into a 4-chamber polystyrene vessel containing tissue culture treated glass slides (Falcon). At 70 % confluence cells were washed once with PBS and fixed using ice cold methanol for 10 min. Methanol was aspirated and slides left to air dry at RT for 15 min then stored at 4C. Prior to IF slides were rehydrated in PBS for 5 min. Each chamber was blocked using 4 drops of 0.5% skimmed milk in PBS (blocking buffer -BB) for 1 hour and 100µl of diluted primary antibody (ab 78946; 1:50 in BB) was applied for 1 hour followed by 3 x 5 min washes in PBS. A control in which primary antibody was omitted was included. Secondary antibody (Alexa Fluor or Texas-Red conjugated) diluted 1:300 in BB was applied for 30 min. After 3x15 min washes with PBS slides were mounted using Prolong gold mountant plus DAPI. Slides were allowed to cure overnight at RT and covered with tin foil prior to imaging with a Zeiss microscope.
Immunohistochemistry (IHC)
Dental pulp tissues were obtained from freshly extracted human third molars as described previously [29] . Pulp tissue was gently separated by sterilized tweezers and the tissue then preserved in 4% formaldehyde for paraffin embedding and sectioning. Tissues were processed in a VIP Tissue processor (Sakura) through 70 % EtOH, 90 % EtOH, 4 changes of 100 % EtOH, 3 changes of 100 % xylene and 3 changes of wax, prior to paraffin embedding. 5 m sections were cut using a Leitz rotary microtome and mounted on glass slides using a 40 °C water bath and slides incubated at 37 °C overnight prior to staining.
Slides were de-waxed at 70 °C on hot plates for 30 minutes prior to antigen retrieval. This was performed in order to enhance the detection of antigen using Mena Path Revelation buffer solution (cat no MP-607-X500) in the Mena Path pressure cooker containing 500 ml distilled water for 40 minutes. Slides were then immersed in PBST (1x PBS containing 0.2% Tween 20) buffer and all remaining steps performed at room temperature. Slides were washed in PBST and blocked with 100 l Novacastra peroxidase (cat no RE7101) for 15 minutes followed by PBST wash. 100 l of protein blocking solution (Novacastra -cat no RE7102) was added for 15 minutes. Primary anti-ER antibody (PPG5/10 or 57/3 both Serotec) was diluted in Zymed antibody diluent and applied for 1 hour and followed by 3x5 min washes in PBST. Both antibodies have been extensively validated for use in IHC [31, 33, 34] . Post primary antibody block (Novolink polymer cat no RE7112) was applied for 30 min followed by 3x5 min PBS washes. The slides then were incubated in diluted DAB chromogen (1:20 v/v) (cat no RE7105) for 5 min. The slides were counterstained in Mayer's Haematoxylin for 1 min and washed under running tap water, then in Scott's tap water substitute for 2 minutes followed by a further wash in running tap water. The slides were dehydrated in a series of graded ethanols (25% for 15 seconds, 50% for 2 minutes, 70% for 5 minutes, and 100% for 5 minutes) and were immersed in xylene 3 times for 3 minutes. The slides were mounted in DPX and left overnight to set prior to scanning using the ScanScope™ system at x20 magnification, and then visualised using ImageScope™ software. For staining of serial sections from demineralised tooth freshly extracted human third molars were washed with dH 2 Oand any attached tissue was removed. Teeth were placed in 10% EDTA solution (300 mg of NaOH was added to the solution to enhance the dissolving process). The solution was changed every 2-3 days. The decalcification process was monitored weekly by x-ray until teeth were completely translucent. Decalcified teeth were paraffin embedded and sectioned as described for pulp tissue.
In vitro bioassay ALP activity was assayed as described previously [35] with some modifications. Briefly DPCs were grown to confluence in PF-DCS. ER agonist (DPN or PPT) was added at the indicated concentrations in osteogenic differentiation medium. Medium (inclusive of ER agonists) was changed at days 4, 7 and 10 and cultures were terminated at day 14. Cells were lysed by the addition of 200ul 0.1% Triton X-100 followed by three cycles of freezethawing. Lysates were centrifuged (5 min; 10000g) and 20ul was assayed for ALP activity.
Data are presented as nmol p-nitrophenol (pNP) formed per ug DNA and represent mean ± SD (n=3).
Statistics
Data were analysed by Student's unpaired t-test (densitometry) or by two way Anova followed by Bonferroni's multiple comparisons test (bioassay) (GraphPad Prism v 7.0) In both instance differences were considered significant at p< 0.05.
Results
Treatment of DPCs with dexamethasone (Dx) and ascorbic acid (AA) caused osteogenic differentiation of DPCs as evidenced by up regulation of early (ALP) and late (OCN) markers of osteogenesis. The transcription factor RunX2 important for the process of osteogenic differentiation was also up regulated at both early (1wk) and late (3wk) time points (Fig 1) . In addition differentiated cell cultures stained positively for both ALP and Alizarin Red an indicator of matrix mineralisation (data not shown). Therefore under our culture conditions differentiation of DPC s was achieved and confirmed recent findings from our laboratories [29] . We next investigated the expression of ER isoforms during differentiation of DPCs. As well as ER and ER we also investigated the expression of the more recently described membrane associated G protein linked ER -GPR30. We found that there was a consistent up regulation of both isoforms of ER which we examined (-1 and -2) at each time point.
Therefore ER 1 was up regulated 27±7, 57±21 and 63±23 fold at days 7, 14 and 21 respectively in differentiating DPCs (mean ± SEM; n=3). For ER 2 corresponding values were 32±9, 53±15 and 53±8 fold at days 7, 14 and 21 (mean ± SEM; n=3). -Fig2. For the other two isoforms of ER examined there was a tendency for down regulation especially at the later time points. Therefore at 21 days in culture ER and GPR30 were down regulated to 62±15 and 64±0.5% respectively of the levels seen in undifferentiated DPCs.
Because ER protein has been largely uncharacterised in DPCs we used 2 extensively validated Mabs to detect ER in lysates prepared from undifferentiated (B) and differentiated (O) cell cultures -see Methods section. WBs indicated a protein of Mr 59kDa which is close to the theoretical Mr for ER 1 (59.2 kDa) -Fig3 .A non-specific cross reacting species was also apparent at Mr ~ 65 kDa. This has previously been described in the ER inducible cell line used to validate Ab288 [32] . Of note however densitometric analysis (Fig 3b) (Fig4) . In addition the presence of both 1 and 2 isoforms was confirmed by IHC using validated and noncross reactive ER isoform specific antibodies (Fig 5) and both ER isoforms were detected in whole pulps obtained after sectioning decalcified third molars (Fig 6) . Interestingly in these whole tooth sections staining for ER 2 was particularly evident in the peripheral pulp (subenamel) layer of tissue which contains mature and precursor odontoblast cells.
Finally we investigated a possible functional role for ER during differentiation of DPCs using alkaline phosphatase (ALP) activity as a marker of osteogenic differentiation as described previously in our laboratories [29] . PPT is a selective agonist of ER (410-fold v ) whereas DPN is an ER selective agonist (70-fold v ) [36, 37] . had little effect on ALP activity. These data suggest that the osteogenic promoting activity of E 2 in DPCs is mediated by the ER isoform.
Discussion
Our observation of ER expression in DPCs confirms previous reports of expression in these cells [21, 22] . Although we report for the first time up regulation of both ER 1 and ER 2 in DPCs during osteogenic differentiation, increased expression of ER during osteogenic differentiation of closely related periodontal ligament stem cells (PDLCs) has been described previously [38] . We characterised ER protein in DPC lysates by WB and in cells Table 1 ). In WB we found a main reactive band with a Mr for the ER species in DPC of 59 kDa ( Figure 3 ). In addition a higher Mr species was identified in WB studies (approx.66kDa). Higher Mr non-specific reactivity with both Ab288 and MC10 has been described although specific reactivity was confirmed at 59kDa using doxycycline inducible ER in the MDA-MB-231 breast cancer cell line [32] . The epitopes recognised by each of the antibodies used in WB lie within the N-terminal portion of ER protein and as such would be expected to recognise both ER 1 and ER 2 isoforms.
However we found no evidence of ER 2 species (Mr 55.5 kDa). Despite the fact that many studies have examined ER isoforms expression by WB in different tissues [38] [39] [40] [41] [42] in most instances these antibodies have not been validated for specific isoform detection using this technique and this area requires further investigation. Although previous studies have assumed that current commercially available pan-ER antibodies detect mainly the ER 1 isoform in WB of cell lysates we note that in our experiments 1 and 2 specific antisera were unreactive with DPC lysate despite previous reports of specific reactivity of these reagents in human Leydig cells [43] , colorectal carcinoma cells [44] and breast tumour tissue [45] . Although there may several reasons for this (sensitivity, specificity, and epitope availability) we note that the lack of reactivity of the ER 1 specific antibody on WB confirms the findings of an extensive validation study reported recently by Nelson et al [32] . In contrast both ER 1 and ER 2 species were detected by IHC (Fig5), a methodology for which the antibodies used have been extensively validated (see above) and this confirms our qRT-PCR data.
There are some functional studies describing E 2 action in cells and tissues within the oral cavity [25, 26, [46] [47] [48] . PDLCs isolated from ovariectomized (OVX) rats showed decreased matrix mineralisation compared to cells derived from sham operated controls and E 2 treatment of OVX derived cell cultures enhanced the osteogenic differentiation of these cultures [28] . Subsequent siRNA transfection of PDLCs suggested a role for both ER and ER isoforms in E 2 mediated action [27, 28] .However, in direct contrast two studies have used siRNA transfection to show that ER is the main ER isoform involved in E 2 stimulated osteogenic differentiation of PDLCs [25, 26] . Although these latter studies are consistent with our findings of ER activity in DPCs using isoform specific agonists (Fig 7) this area requires further investigation. There is also conflicting data concerning the signalling pathways used by E 2 during stimulation of osteogenic differentiation of DPCs with reports that activation [18] or inhibition [17] of NF-B is required for differentiation of DPCs to a matrix mineralising phenotype. In stem cells from apical papillae (SCAP) E 2 is reported to stimulate osteogenesis via activation of the MAPK pathway [49] although whether this pathway is activated in DPCs is currently unknown. Although there are no other reports on GPR30 expression in dental tissues recent studies using membrane impermeable E2 conjugates and phytoestrogens suggest that this cell membrane ER can be activated in DPCs and PDLCs [46, 50] and this is an area worthy of further study.
We report dissociation between ER mRNA and protein expression. ER 1 and 2 mRNA is up regulated several fold during osteogenic differentiation of DPCs but such changes are not translated into differences in protein levels (Figs 2 and 3) . A disconnection between ER mRNA and protein levels has been reported by other workers [51, 52] , with work on breast cancer suggesting this may be as a result of translational control [53, 54] .This is also an area worthy of further investigation. Finally differentiation of DPCs in our laboratories is achieved with dexamethasone and ascorbic acid and it is important to confirm that changes in ER expression are due to differentiation per se and not to the independent action of either agent. Although a previous report suggested that dexamethasone had no effect on ER mRNA expression in discrete rat CNS nuclei [51] it will be important to establish that ER is up regulated under dexamethasone free differentiating conditions. The osteogenic differentiation of stem cells derived from subcutaneous adipose tissue (ASCs) and bone marrow (BM-MSCs) in the absence of dexamethasone has been described previously [55] and such experiments on DPCs are currently underway in our laboratories. n=3. In some instances symbol size is larger than SD. Analysis was by two-way Anova followed by Bonferroni's multiple comparisons test * p< 0.05;** p< 0.0001. Table 1S Details for ER antibodies used in the current study. 
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